WebGSK3745417 STING cytosolic DNA pathway agonist GSK6097608 CD96 antagonist GSK3901961 Engineered TCR T-cells, co-expressing the CD8a cell surface receptor, targeting NY-ESO-1 GSK3845097 Engineered TCR T-cells, co-expressing the dnTGF-βRII cell surface receptor, targeting NY-ESO-1 HIV and Infectious Diseases HIV integrase … WebGSK3745417 STING agonist. First-time-in-human study of GSK3745417 alone or in combination with dostarlimab in patients with advanced solid tumors ... associated …
The Sting is dead; long live the Sting Evaluate
Webgsk3745417 Report issue. Biologics Peptide Experimental. Active Ingredient History < Back; View all... NOW. Now; Organizations (1) ... Mechanism of Action: STING Multi-specific: … WebGSK3745417 STING cytosolic DNA pathway agonist GSK6097608 CD96 antagonist GSK3901961 Engineered TCR T-cells, co-expressing the CD8a cell surface receptor, targeting NY-ESO-1 GSK3845097 Engineered TCR T-cells, co-expressing the dnTGF-βRII cell surface receptor, targeting NY-ESO-1 HIV and Infectious Diseases HIV integrase … pace university registrar office phone number
Sting Agonist GSK3745417 Induces Apoptosis, Antiproliferation, …
WebMechanism of Action / Vaccines Type Current Phase In-licensed or other Alliance Relationships GSK4057190 (TSR-042) dostarlimab Jemperli Oncology 1L Endometrial … WebStimulator of interferon genes (STING) is a key adapter molecule that mediates sensing of cytosolic DNA and activates T‑cell–dependent tumor immunity. 1 GSK3745417 is a … WebGSK3745417 STING cytosolic DNA pathway agonist GSK6097608 HIV integrase inhibitor Registration GSK1265744 cabotegravir GSK2140944 gepotidacin triazaacenaphthylene bacterial type II topoisomerase inhibitor COVID-19 anti-spike protein antibody GSK3036656 Tuberculosis Leucyl t-RNA synthetase inhibitor Phase II GSK3228836 Hepatitis B HBV … jennings county indiana gis mapping